CAMERA, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 236
AS - Asia 106
EU - Europa 93
AF - Africa 3
SA - Sud America 2
Totale 440
Nazione #
US - Stati Uniti d'America 228
SG - Singapore 45
IT - Italia 44
CN - Cina 34
HK - Hong Kong 18
NL - Olanda 11
FI - Finlandia 10
CA - Canada 8
IE - Irlanda 8
RU - Federazione Russa 7
DE - Germania 6
IN - India 4
VN - Vietnam 4
CI - Costa d'Avorio 3
UA - Ucraina 3
BR - Brasile 2
AT - Austria 1
GB - Regno Unito 1
MD - Moldavia 1
SE - Svezia 1
TR - Turchia 1
Totale 440
Città #
Chandler 54
Singapore 30
Santa Clara 19
Hong Kong 18
Ashburn 16
Millbury 12
Nanjing 11
Amsterdam 10
Napoli 9
Seattle 9
Beijing 8
Des Moines 7
Ottawa 7
Princeton 7
Helsinki 6
Naples 6
Boston 5
Falkenstein 5
Dong Ket 4
Pomigliano D'arco 4
Shenyang 4
Dearborn 3
Jacksonville 3
Lawrence 3
Dallas 2
Gualtieri 2
Hebei 2
Ischia 2
Nanchang 2
Redwood City 2
Sorrento 2
Vittorio Veneto 2
Wilmington 2
Bari 1
Brasília 1
Chisinau 1
Curitiba 1
Dalian 1
Huizhou 1
Hyderabad 1
Istanbul 1
Los Angeles 1
Milan 1
Pune 1
San Diego 1
San Jose 1
Stockholm 1
Tianjin 1
Toronto 1
Vienna 1
Vijayawada 1
Totale 296
Nome #
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 73
Eradication of HCV in Renal Transplant Recipients and Its Effects on Quality of Life 54
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 50
No differences of response to telaprevir based therapy in cirrhotic and non cirrhotic patients with RVR: a real life data from South Italy. Hepatology 2014; 60 (S1): 695A-696A. Abstract. 1018 50
Prevalence of and risk factors for HBV infection in a metropolitan Southern Italian area: Evidence for the effectiveness of universal Hepatitis B vaccination 46
Coffee and liver health 44
Impact of telaprevir in HCV patients with cirrhosis and RVR: real-life data from Boceprevir or Telaprevir based "triple therapy" experience in southern Italy 39
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis 39
Osteoporosis across chronic liver disease 37
Optimization of direct anti-viral agent treatment schedule: Focus on HCV genotype 3 32
Totale 464
Categoria #
all - tutte 2.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.180


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015 0 0 0 0 0 0 0 0 1 4 6 4
2020/202120 3 0 1 2 4 2 1 0 2 0 1 4
2021/202255 0 0 0 0 0 0 2 1 9 6 12 25
2022/2023109 10 5 1 9 21 13 0 17 16 15 2 0
2023/202465 3 11 7 3 1 14 0 11 2 3 9 1
2024/2025122 14 8 1 2 12 29 27 24 5 0 0 0
Totale 464